Wird geladen...
Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors
ABSTRACT: BACKGROUND: Monoclonal antibodies have become attractive clinical anti-cancer drugs in the last 3 decades due to their targeting specificity and suitable pharmacokinetic properties. Mesothelin is a tumor-associated antigen with limited expression in normal tissues. It is frequently over-ex...
Gespeichert in:
| Veröffentlicht in: | Clin Cancer Drugs |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Bentham Science Publishers
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5080863/ https://ncbi.nlm.nih.gov/pubmed/27853672 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/2212697X03666160218215744 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|